Ironwood Pharmaceuticals Announces CEO Transition
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Ironwood Pharma (IRWD) on Watch as Sale Potential Moves Higher - Analyst
February 9, 2021 9:59 AM ESTGordon Haskett analyst Don Bilson said odds that Ironwood Pharma (NASDAQ: IRWD) will be sold "crept higher" after it was announced CEO Mark Mallon will be leaving the company next month.
Bilson said their guess would be the period... More
